Michelle Quinn
Known title: EVP, GC and SecretaryCIK: 0001964281
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BDX Revello Stent Trial Success, Revenue Up 5.4%, Earnings Down 34%. The company announced that its Revello stent achieved strong results in the AGILITY trial for peripheral artery disease patients. Revenue rose 5.4% year‑over‑year, but net earnings fell 34.3%, reflecting higher costs or lower margins. The dividend yield sits at 1.59% and analysts see a target of $194, while the stock trades near the top of its 52‑week range.
Transaction History
| MDT | ▲ Buy | Grant | 6,346 | $0 | 8/3/2026 | View on chart |
| MDT | ▼ Sell | Tax Withholding | 2,069 | $180K | 7/28/2026 | View on chart |
| MDT | ▲ Buy | Grant | 16,310 | $0 | 7/28/2025 | View on chart |
| MDT | ▲ Buy | Grant | 5,437 | $0 | 7/28/2025 | View on chart |
| BDX | ▲ Buy | Grant | 1,932 | $0 | 11/26/2024 | View on chart |
| BDX | ▲ Buy | Grant | 416 | $0 | 11/26/2024 | View on chart |
| BDX | ▼ Sell | Tax Withholding | 376 | $0 | 11/26/2024 | View on chart |
| BDX | ▲ Buy | Grant | 1,206 | $0 | 11/26/2023 | View on chart |
| BDX | ▲ Buy | Grant | 909 | $0 | 11/26/2023 | View on chart |
| BDX | ▼ Sell | Tax Withholding | 440 | $0 | 11/26/2023 | View on chart |
| BDX | ▼ Sell | Tax Withholding | 99 | $0 | 5/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MiniMed completes separation from Medtronic
Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.
MiniMed completes separation from Medtronic. Medtronic has finalized the separation of its MiniMed insulin pump business, which is now operating as an independent company with a new board of directors. This corporate restructuring marks a significant shift in Medtronic's portfolio structure. Meanwhile, the company was named to the TIME Best Inventions of 2026 list for its Stealth AXiS surgical system and Corsano wearable, highlighting continued innovation in its remaining product lines.